About Bioluz
Our process is highly automated and robotized, with no human intervention, in a state-of-the-art facility inaugurated in 2010.
This unique industrial capacity for Europe extends the range of IV drugs that can be presented in flexible bags as a Premixed drug (ready-to-use) to heat sensitive molecules.
Bioluz offers to :
- Perform the technology transfer project of your product within agreed timelines with a dedicated senior project team - Manufacture trial batches of reduced sizes
- Manufacture validation batches and provide validation data
- Perform stability studies under specific ICH conditions
- Support your dossier compilation and submission
- Support your product launch
- Supply your commercial needs within agreed timelines
Schedule of events
  |
Press ReleasesFebruary, 2011 Bioluz dévoile sa ligne aseptique
February 24th, 2010 Kit de reconstitution d'injectables sans aiguille
January 1st, 2010 Needle-free diluent technology
October 26th, 2009 Bioluz and Actavis enter co-development relationship for IV pharmaceuticals
|
|||||
Related links
|
||||||
Bioluz is a fully integrated and independent CMO offering